Site Search
Professionals 224 results
Capabilities 36 results
Industry
The medical device industry is currently undergoing monumental change—from supply chain challenges to disruptive technologies and economic fluctuations. To pave the way for a more accessible and innovative healthcare landscape—including advances in wearables, implants, diagnostics, mobility, drug delivery—the evolving and expansive medical device industry faces wide-ranging legal needs. Clients in this sector can tap the remarkable depth and breadth of our sector-focused and skilled attorneys in the U.S. and abroad. Our Healthcare & Life Sciences Industry Group engages clients at all points in the product development life cycle to provide sound advice and practical solutions regardless of the client’s size or the complexity of their need. We help clients navigate today’s complex regulatory landscape, defend products and reputations in the face of high-profile product liability and mass tort claims, protect innovative intellectual property (IP), and leverage cross-border experience to advise on commercial transactions.
Industry
Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations.
Practice Area
As a firm of choice for many major businesses, we represent employers, fiduciaries, boards of directors, benefit plans, and plan administrators in all aspects of ERISA litigation, including claims relating to fiduciary liability, plan investments, excessive fees, plan qualification, plan termination, reversion of excess assets, retiree medical benefits, severance and employment contract matters, tax liability matters, and retirement and welfare benefit claims.
Experience 33 results
Experience
|November 15, 2024
Winston Represented Revelstoke Capital Partners in Acquisition of NKMD MGMT, LLC
Winston represented Revelstoke Capital Partners, a healthcare-focused private equity firm, in the acquisition of NKMD Mgmt, LLC, a provider of services including fillers, toxins, and other aesthetics treatments in over 20 locations across California, Arizona and Nevada. As the medical aesthetics industry continues to grow, this partnership between Revelstoke and NKMD will help build an industry leader with a strong commitment to clinical quality, safety, and patient experience.
Experience
|November 11, 2024
A team led by Craig Godshall and Matthew Schlosser represented Court Square Capital Partners, a New York-based leading middle-market private equity company, in its entry into a definitive agreement to sell Advanced Diabetes Supply® Group, a California-based national distributor of Durable Medical Equipment specializing in diabetes supplies, to Cardinal Health for US$1.1B. This sale will allow ADSG to continue to expand its reach and enhance the way it serves its approximately 500,000 patients nationwide with advances in in-home delivery of diabetes products including continuous glucose monitoring devices and other testing supplies.
Experience
|September 25, 2024
Winston represents the founding partners of EDL in a new LBO
Winston & Strawn Paris is advising the founding partners of EDL in the sale of a majority stake to Dentressangle Participations.
Insights & News 796 results
Benefits Blast
|December 18, 2025
|5 Min Read
The Internal Revenue Service (the IRS) recently issued Notice 2026-5 which provides guidance on changes to health saving accounts (HSAs) enacted by the One Big Beautiful Bill Act (OBBBA).
Pro Bono In Action
|November 24, 2025
|2 Min Read
Winston Safeguards the Medical Privacy Rights of Transgender Teens in Texas
A multi-office Winston team successfully opposed the Texas Attorney General’s unprecedented attempt to use nonparty civil discovery to secure the private medical records of 30+ transgender teenagers.
Client Alert
|November 11, 2025
|3 Min Read
On October 6, 2025, California Governor Gavin Newsom signed Senate Bill 351 (SB 351 or the Bill) into law, codifying certain prohibitions on the corporate practice of medicine and the use of certain restrictive covenants in the ownership and management of physician and dental practices. SB 351 aims to ensure that clinical decisions are exclusively made by licensed healthcare providers.
Other Results 21 results
Law Glossary
The FDA stands for the Food and Drug Administration. It is a federal agency charged with protecting the public by regulating the safety and security of drugs, biological products, veterinary medications, and medical devices. FDA responsibilities also cover the safety of: foods for U.S. consumers, cosmetics, animal feed, and radiation-emitting products. Various rules may be established and enforced by the agency in response to U.S. laws or presidential executive orders.
Site Content
In the product liability context, a failure to warn claim arises when a plaintiff alleges that a product lacked an adequate warning regarding potential risks associated with its use. To succeed in a failure to warn claim, a plaintiff typically needs to demonstrate that the lack of a warning regarding a particular potential harm rendered the product unreasonably dangerous, and that adequate warnings would have ultimately prevented the alleged harm.
Law Glossary
Consumer privacy law is the legal area covering violations of personal information and the right to privacy in everyday life, including violations relating to technology use and finances. Consumer privacy laws and regulations protect individuals from privacy loss due to the failures and limitations of corporate customer privacy measures. The Federal Trade Commission (FTC) is the primary agency directing federal privacy policies and enforcing associated regulations. The FTC utilizes law enforcement, creates policy, and educates consumers as it acts to protect privacy. Legal action can be taken against organizations that violate consumer privacy rights, especially regarding sensitive information.